Profile
Gore Range Capital is a specialized healthcare investment firm based in New York, founded in 2015. The firm is led by a team comprising Managing Partner Ethan Rigel, Principal Chidi Nwankpa, and other expert partners and scientific advisors focused on creating innovative healthcare solutions. Gore Range Capital combines the operational discipline of private equity and the scientific partnership model of venture investing, differentiating itself by leveraging deep domain expertise and strategic clinical guidance.
Gore Range Capital invests in sectors such as precision health, regenerative medicine, personalized therapeutics, longevity, and restorative medical sciences. The firm is committed to improving functional health and enhancing quality of life through platforms that are scalable and clinically validated. With a strategic focus on healthcare solutions that address aging and chronic diseases, Gore Range Capital supports companies that combine scientific discovery with clinical and commercial scalability.
The firm's notable investments include AOA - precision health, Claret - medical device, Or-Genix - skin therapeutics, Rhamnopharma - regenerative medicine, and Avive - healthcare technology. These companies illustrate Gore Range Capital's dedication to fostering innovative solutions that enhance long-term well-being and healthspan.
Industry
Gore Range Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Gore Range Capital Fund I
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
—
|
January 2019
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.